Skip to the beginning of the images gallery

Levofloxacin - 98.0-102.0% anhydrous basis (HPLC), high purity , CAS No.100986-85-4

anhydrous
Moligand™
≥98%

CAS#: 100986-85-4
Formula: C₁₈H₂₀FN₃O₄
Molecular Weight: 361.37
MDL number: MFCD00865049
PubChem CID: 149096

Item Number

L473790

Grouped product items
SKU	Size	Availability	Price
L473790-10mg	10mg	In stock	$23.90
L473790-1g	1g	In stock	$102.90
L473790-10g	10g	Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!	$228.90

Basic Description

Synonyms	LEVOFLOXACIN\|100986-85-4\|Levaquin\|Quixin\|(-)-Ofloxacin\|Cravit\|Iquix\|Tavanic\|Ofloxacin S-(-)-form\|Levofloxacine\|(S)-Ofloxacin\|L-Ofloxacin\|Levofloxacino\|Levofloxacinum\|Elequine\|Oftaquix\|Levofloxacin Anhydrous\|Floxacin\|Volequin\|Nofaxin\|(S)-(-)-Ofloxacin\|DR-3
Specifications & Purity	98.0-102.0% anhydrous basis (HPLC)
Grade	anhydrous, Moligand™
Product Description	Description Levofloxacin is a broad-spectrum antibiotic used in pharmacokinetic , antibiotic resistance , and resistance prevention studies. Antibiotic against bacterial respiratory tract infections.

Names and Identifiers

IUPAC Name	(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
INCHI	InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)/t10-/m0/s1
InChi Key	GSDSWSVVBLHKDQ-JTQLQIEISA-N
Canonical SMILES	CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
Isomeric SMILES	C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
RTECS	UU8815550
PubChem CID	149096
Molecular Weight	361.37
Reaxy-Rn	5385660

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

2 results found

Lot Number	Certificate Type	Date	Item
I2320578	Certificate of Analysis	Sep 22, 2023	L473790
I2320589	Certificate of Analysis	Sep 22, 2023	L473790

Chemical and Physical Properties

Specific Rotation[α]	-66° (C=5,CHCl3)
Melt Point(°C)	224 °C

Safety and Hazards(GHS)

Pictogram(s)	GHS08, GHS07
Signal	Danger
Hazard Statements	H302:Harmful if swallowed H317:May cause an allergic skin reaction H334:May cause allergy or asthma symptoms or breathing difficulties if inhaled H361:Suspected of damaging fertility or the unborn child H362:May cause harm to breast-fed children
Precautionary Statements	P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P260:Do not breathe dust/fume/gas/mist/vapors/spray. P284:[In case of inadequate ventilation] Wear respiratory protection. P270:Do not eat, drink or smoke when using this product. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P272:Contaminated work clothing should not be allowed out of the workplace. P333+P313:IF SKIN irritation or rash occurs: Get medical advice/attention. P362+P364:Take off contaminated clothing and wash it before reuse. P330:Rinse mouth. P263:Avoid contact during pregnancy/while nursing. P203:Obtain, read and follow all safety instructions before use. P301+P317:IF SWALLOWED: Get medical help. P318:if exposed or concerned, get medical advice. P342+P316:If experiencing respiratory symptoms: Get emergence medical help immediately.
RTECS	UU8815550
Reaxy-Rn	5385660
Merck Index	6771

References

1. Cui L, Neoh HM, Shoji M, Hiramatsu K. (2009) Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.. Antimicrob Agents Chemother, 53 (3): (1231-4). [PMID:19124662]
2. Brown SD, Traczewski MM. (2010) Comparative in vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control ranges.. Antimicrob Agents Chemother, 54 (5): (2063-9). [PMID:20231392]
3. Koga T, Sugihara C, Kakuta M, Masuda N, Namba E, Fukuoka T. (2009) Affinity of Tomopenem (CS-023) for penicillin-binding proteins in Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.. Antimicrob Agents Chemother, 53 (3): (1238-41). [PMID:19104025]
4. Waites KB, Crabb DM, Duffy LB. (2008) Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.. Antimicrob Agents Chemother, 52 (10): (3776-8). [PMID:18663020]
5. Petersen PJ, Jones CH, Venkatesan AM, Mansour TS, Projan SJ, Bradford PA. (2009) Establishment of in vitro susceptibility testing methodologies and comparative activities of piperacillin in combination with the penem {beta}-lactamase inhibitor BLI-489.. Antimicrob Agents Chemother, 53 (2): (370-84). [PMID:19001109]
6. George G Zhanel,Kelly Ennis,Lavern Vercaigne,Andrew Walkty,Alfred S Gin,John Embil,Heather Smith,Daryl J Hoban. (2002-01-16) A critical review of the fluoroquinolones: focus on respiratory infections.. Drugs, 62 ((1)): (13-59). [PMID:11790155]
7. Miriam Hurst,Harriet M Lamb,Lesley J Scott,David P Figgitt. (2002-09-25) Levofloxacin: an updated review of its use in the treatment of bacterial infections.. Drugs, 62 ((14)): (2127-2167). [PMID:12269858]
8. Ying Ying Chan,Yong Mei Ong,Kim Lee Chua. (2006-12-06) Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei.. Antimicrobial agents and chemotherapy, 51 ((2)): (623-630). [PMID:17145801]
9. Arnold Louie,Mark R Deziel,Weiguo Liu,George L Drusano. (2007-05-23) Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.. Antimicrobial agents and chemotherapy, 51 ((8)): (2661-2667). [PMID:17517837]
10. Laura Calatayud,C Ardanuy,E Cercenado,A Fenoll,E Bouza,R Pallares,R Martín,J Liñares. (2007-07-04) Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.. Antimicrobial agents and chemotherapy, 51 ((9)): (3240-3246). [PMID:17606677]
11. Kunikazu Yamane,Jun-ichi Wachino,Satowa Suzuki,Yoshichika Arakawa. (2008-02-21) Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan.. Antimicrobial agents and chemotherapy, 52 ((4)): (1564-1566). [PMID:18285488]
12. Inna Chmelnitsky,Shiri Navon-Venezia,Jacob Strahilevitz,Yehuda Carmeli. (2008-06-04) Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.. Antimicrobial agents and chemotherapy, 52 ((8)): (2962-2965). [PMID:18519713]
13. Lauren Becnel Boyd,Merry J Maynard,Sonia K Morgan-Linnell,Lori Banks Horton,Richard Sucgang,Richard J Hamill,Javier Rojo Jimenez,James Versalovic,David Steffen,Lynn Zechiedrich. (2008-10-08) Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates.. Antimicrobial agents and chemotherapy, 53 ((1)): (229-234). [PMID:18838594]
14. George V Tetz,Natalia K Artemenko,Victor V Tetz. (2008-12-10) Effect of DNase and antibiotics on biofilm characteristics.. Antimicrobial agents and chemotherapy, 53 ((3)): (1204-1209). [PMID:19064900]
15. Daniela Baldoni,Manuel Haschke,Zarko Rajacic,Werner Zimmerli,Andrej Trampuz. (2008-12-17) Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection.. Antimicrobial agents and chemotherapy, 53 ((3)): (1142-1148). [PMID:19075065]
16. Florian M E Wagenlehner,Christine Wagenlehner,Rebecca Redman,Wolfgang Weidner,Kurt G Naber. (2009-02-04) Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis.. Antimicrobial agents and chemotherapy, 53 ((4)): (1567-1573). [PMID:19188391]
17. Marina Cerquetti,Aurora García-Fernández,Maria Giufrè,Daniela Fortini,Marisa Accogli,Caterina Graziani,Ida Luzzi,Alfredo Caprioli,Alessandra Carattoli. (2009-05-20) First report of plasmid-mediated quinolone resistance determinant qnrS1 in an Escherichia coli strain of animal origin in Italy.. Antimicrobial agents and chemotherapy, 53 ((7)): (3112-3114). [PMID:19451298]
18. Emma Padilla,Enrique Llobet,Antonio Doménech-Sánchez,Luis Martínez-Martínez,José Antonio Bengoechea,Sebastián Albertí. (2009-10-28) Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence.. Antimicrobial agents and chemotherapy, 54 ((1)): (177-183). [PMID:19858254]
19. Manthena V S Varma,R Scott Obach,Charles Rotter,Howard R Miller,George Chang,Stefanus J Steyn,Ayman El-Kattan,Matthew D Troutman. (2010-01-15) Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.. Journal of medicinal chemistry, 53 ((3)): (1098-1108). [PMID:20070106]
20. Yu-Chi Lin,Ko-Chiang Hsia,Yee-Chun Chen,Wang-Huei Sheng,Shan-Chwen Chang,Mei-Hui Liao,Shu-Ying Li. (2010-03-03) Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan.. Antimicrobial agents and chemotherapy, 54 ((5)): (2078-2084). [PMID:20194701]
21. Matthew G Blango,Matthew A Mulvey. (2010-03-17) Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.. Antimicrobial agents and chemotherapy, 54 ((5)): (1855-1863). [PMID:20231390]
22. Renato Pires,Carmen Ardanuy,Dora Rolo,Ana Morais,António Brito-Avô,José Gonçalo-Marques,Josefina Liñares,Ilda Santos-Sanches. (2010-03-31) Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.. Antimicrobial agents and chemotherapy, 54 ((6)): (2677-2680). [PMID:20350943]
23. Michael J Zapor,Melissa Barber,Amy Summers,George H Miller,Lee Ann Feeney,Lynn E Eberly,Glenn Wortmann. (2010-04-21) In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center.. Antimicrobial agents and chemotherapy, 54 ((7)): (3015-3017). [PMID:20404121]
24. Stephen P Hawser,Samuel K Bouchillon,Daryl J Hoban,Robert E Badal,Rafael Cantón,Fernando Baquero. (2010-04-28) Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART).. Antimicrobial agents and chemotherapy, 54 ((7)): (3043-3046). [PMID:20421398]
25. Renu Singh,Kimberly R Ledesma,Kai-Tai Chang,Vincent H Tam. (2010-07-28) Impact of recA on levofloxacin exposure-related resistance development.. Antimicrobial agents and chemotherapy, 54 ((10)): (4262-4268). [PMID:20660686]
26. Alka Khanna,V Samuel Raj,Bansidhar Tarai,Ruchi Sood,Pawan Kumar Pareek,Dilip J Upadhyay,Pawan Sharma,Ashok Rattan,Kulvinder Singh Saini,Harpal Singh. (2010-08-18) Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.. Antimicrobial agents and chemotherapy, 54 ((11)): (4789-4793). [PMID:20713679]
27. Ju-Xian Wang,Yi-Bin Zhang,Ming-Liang Liu,Bo Wang,Yun Chai,Su-Jie Li,Hui-Yuan Guo. (2011-04-13) Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-4-amino-4-methylpiperidin-1-yl) fluoroquinolone derivatives.. European journal of medicinal chemistry, 46 ((6)): (2421-2426). [PMID:21481984]
28. Geetha Ramachandran,Vedachalam Chandrasekaran,Agibothu Kupparam Hemanth Kumar,Puneet Dewan,Soumya Swaminathan,Aleyamma Thomas. (2013-08-14) Estimation of content of anti-TB drugs supplied at centres of the Revised National TB Control Programme in Tamil Nadu, India.. Tropical medicine & international health : TM & IH, 18 ((9)): (1141-1144). [PMID:23937703]
29. Kazutaka Kamiya,Kimiya Shimizu,Akihito Igarashi,Hidenaga Kobashi. (2014-04-05) Factors influencing long-term regression after posterior chamber phakic intraocular lens implantation for moderate to high myopia.. American journal of ophthalmology, 158 ((1)): (179-184). [PMID:24699155]
30. Jikun Du,Peipei Li,Helu Liu,Dongyue Lü,Hong Liang,Yuhong Dou. (2014-04-18) Phenotypic and molecular characterization of multidrug resistant Klebsiella pneumoniae isolated from a university teaching hospital, China.. PloS one, 9 ((4)): (e95181-e95181). [PMID:24740167]
31. Saira Furqan,Saleem Amin Ullah Paracha. (2014-05-29) Frequency of Streptococcus pneumonia and Haemophilus influenza in acute exacerbation of chronic obstructive airway disease and their sensitivity to levofloxacin.. JPMA. The Journal of the Pakistan Medical Association, 64 ((4)): (399-402). [PMID:24864632]
32. Dong Hui Lim,Min Gyu Lee,Eui-Sang Chung,Tae-Young Chung. (2014-06-22) Clinical results of posterior chamber phakic intraocular lens implantation in eyes with low anterior chamber depth.. American journal of ophthalmology, 158 ((3)): (447-454). [PMID:24952274]
33. Yuan Zhang,Li-Qin Zhu,Nan Wang,Xuequn Zhao,Wenjie Yang,Shuangmin Ji,Liying Sun. (2014-07-31) Population pharmacokinetics of intravenous levofloxacin 500 mg/day dosage in infected patients.. Die Pharmazie, 69 ((7)): (553-557). [PMID:25073403]
34. Huabin Zheng,Zhuhong Zhang,Na Luo,Yuanyuan Liu,Qingzhong Chen,Hua Yan. (2014-08-12) Increased Th17 cells and IL‑17 in rats with traumatic optic neuropathy.. Molecular medicine reports, 10 ((4)): (1954-1958). [PMID:25110203]
35. Fatima Kamal,Jonathan J Dennis. (2014-12-03) Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity.. Applied and environmental microbiology, 81 ((3)): (1132-1138). [PMID:25452284]
36. Kyungmin Lee,Joonhong Sohn,Jong Gil Choi,Sung Kun Chung. (2014-12-04) Optical quality in central serous chorioretinopathy.. Investigative ophthalmology & visual science, 55 ((12)): (8598-8603). [PMID:25468888]
37. Thi-Sau Migone,Sally Bolmer,John Zhong,Al Corey,Daphne Vasconcelos,Matthew Buccellato,Gabriel Meister. (2014-12-10) Added benefit of raxibacumab to antibiotic treatment of inhalational anthrax.. Antimicrobial agents and chemotherapy, 59 ((2)): (1145-1151). [PMID:25487792]
38. Taeyeon Kim,Geunu Bak,Juyeon Lee,Kwang-Sun Kim. (2015-03-01) Systematic analysis of the role of bacterial Hfq-interacting sRNAs in the response to antibiotics.. The Journal of antimicrobial chemotherapy, 70 ((6)): (1659-1668). [PMID:25724987]
39. Dougal H Adamson,Vasare Krikstopaityte,Peter J Coote. (2015-04-30) Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.. The Journal of antimicrobial chemotherapy, 70 ((8)): (2271-2278). [PMID:25921513]
40. Ayumu Ito,Hidemasa Nakaminami,Takeshi Fujii,Kenta Utsumi,Norihisa Noguchi. (2015-05-03) Increase in SCCmec type IV strains affects trends in antibiograms of meticillin-resistant Staphylococcus aureus at a tertiary-care hospital.. Journal of medical microbiology, 64 ((7)): (745-751). [PMID:25934550]
41. Sushmita D Lahiri,Amy Kutschke,Kathy McCormack,Richard A Alm. (2015-06-17) Insights into the mechanism of inhibition of novel bacterial topoisomerase inhibitors from characterization of resistant mutants of Staphylococcus aureus.. Antimicrobial agents and chemotherapy, 59 ((9)): (5278-5287). [PMID:26077256]
42. Olli Wetterstrand,Juha M Holopainen,Kari Krootila. (2015-07-15) Femtosecond Laser-Assisted Intrastromal Relaxing Incisions After Penetrating Keratoplasty: Effect of Incision Depth.. Journal of refractive surgery (Thorofare, N.J. : 1995), 31 ((7)): (474-479). [PMID:26158928]
43. Masamichi Fukuda,Hiroshi Sasaki. (2015-07-18) Effects of Fluoroquinolone-Based Antibacterial Ophthalmic Solutions on Corneal Wound Healing.. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 31 ((9)): (536-540). [PMID:26186125]
44. David A Bookstaver,Christopher M Bland,Miguel A Arroyo. (2015-07-30) Evaluation of cefazolin as a surrogate marker for cefpodoxime susceptibility for urinary tract isolates.. Journal of medical microbiology, 64 ((10)): (1170-1173). [PMID:26219948]
45. Robert Skov,Erika Matuschek,Maria Sjölund-Karlsson,Jenny Åhman,Andreas Petersen,Marc Stegger,Mia Torpdahl,Gunnar Kahlmeter. (2015-08-21) Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica.. Journal of clinical microbiology, 53 ((11)): (3411-3417). [PMID:26292292]
46. J M Rodríguez-Martínez,C Velasco,I García,M E Cano,L Martínez-Martínez,A Pascual. (2007-04-04) Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1.. Antimicrobial agents and chemotherapy, 51 ((6)): (2236-2239). [PMID:17404007]
47. Margaret Ip,Shirley S L Chau,Fang Chi,Julian Tang,Paul K Chan. (2007-06-06) Fluoroquinolone resistance in atypical pneumococci and oral streptococci: evidence of horizontal gene transfer of fluoroquinolone resistance determinants from Streptococcus pneumoniae.. Antimicrobial agents and chemotherapy, 51 ((8)): (2690-2700). [PMID:17548487]
48. Jian Lv,Yunbo Qian,Tingting Liu,Yongmei Wang. (2007-06-16) Synthesis and evaluation of amphiphilic cationic quinine-derived for antibacterial activity against methicillin-resistant Staphylococcus aureus.. Bioorganic & medicinal chemistry letters, 17 ((15)): (4102-4106). [PMID:17570664]
49. F Morio,H Jean-Pierre,L Dubreuil,E Jumas-Bilak,L Calvet,G Mercier,R Devine,H Marchandin. (2007-10-10) Antimicrobial susceptibilities and clinical sources of Dialister species.. Antimicrobial agents and chemotherapy, 51 ((12)): (4498-4501). [PMID:17923492]
50. Takeshi Hirano,Satoru Yasuda,Yuki Osaka,Masaru Asari,Masaki Kobayashi,Shirou Itagaki,Ken Iseki. (2007-11-06) The inhibitory effects of fluoroquinolones on L-carnitine transport in placental cell line BeWo.. International journal of pharmaceutics, 351 ((1-2)): (113-118). [PMID:17977676]
51. Zhiyong Zong,Sally R Partridge,Jonathan R Iredell. (2007-11-21) RmtC 16S rRNA methyltransferase in Australia.. Antimicrobial agents and chemotherapy, 52 ((2)): (794-795). [PMID:18025117]
52. Patricia J Baudry,Kim Nichol,Melanie DeCorby,Laura Mataseje,Michael R Mulvey,Daryl J Hoban,George G Zhanel. (2008-02-27) Comparison of antimicrobial resistance profiles among extended-spectrum-beta-lactamase-producing and acquired AmpC beta-lactamase-producing Escherichia coli isolates from Canadian intensive care units.. Antimicrobial agents and chemotherapy, 52 ((5)): (1846-1849). [PMID:18299417]
53. Yu-Chia Hsieh,Kuang-Yi Chang,Yi-Chuan Huang,Hsiao-Chuan Lin,Yu-Huai Ho,Li-Min Huang,Po-Ren Hsueh. (2008-04-17) Clonal spread of highly beta-lactam-resistant Streptococcus pneumoniae isolates in Taiwan.. Antimicrobial agents and chemotherapy, 52 ((6)): (2266-2269). [PMID:18413298]
54. Kenichiro Shimizu,Ken Kikuchi,Takashi Sasaki,Namiko Takahashi,Masayuki Ohtsuka,Yuka Ono,Keiichi Hiramatsu. (2008-07-23) Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia.. Antimicrobial agents and chemotherapy, 52 ((10)): (3823-3825). [PMID:18644963]
55. Marianne Gunell,Mark A Webber,Pirkko Kotilainen,Andrew J Lilly,Jonathan M Caddick,Jari Jalava,Pentti Huovinen,Anja Siitonen,Antti J Hakanen,Laura J V Piddock. (2009-07-15) Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance phenotype.. Antimicrobial agents and chemotherapy, 53 ((9)): (3832-3836). [PMID:19596880]
56. Milagrosa Montes,Esther Tamayo,Beatriz Orden,Julián Larruskain,Emilio Perez-Trallero. (2009-10-07) Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain.. Antimicrobial agents and chemotherapy, 54 ((1)): (93-97). [PMID:19805559]
57. Yun Cai,Ran Li,Beibei Liang,Nan Bai,Youning Liu,Rui Wang. (2010-06-30) In vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii.. Antimicrobial agents and chemotherapy, 54 ((9)): (3998-3999). [PMID:20585134]
58. Paul G Higgins,Thamarai Schneiders,Axel Hamprecht,Harald Seifert. (2010-10-06) In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.. Antimicrobial agents and chemotherapy, 54 ((12)): (5021-5027). [PMID:20921306]
59. Joëlle Azéma,Brigitte Guidetti,Alexander Korolyov,Robert Kiss,Christine Roques,Patricia Constant,Mamadou Daffé,Myriam Malet-Martino. (2011-11-01) Synthesis of lipophilic dimeric C-7/C-7-linked ciprofloxacin and C-6/C-6-linked levofloxacin derivatives. Versatile in vitro biological evaluations of monomeric and dimeric fluoroquinolone derivatives as potential antitumor, antibacterial or antimycobacterial agents.. European journal of medicinal chemistry, 46 ((12)): (6025-6038). [PMID:22036229]
60. Wardhana,E A Datau. (2013-01-15) A patient with allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans.. Acta medica Indonesiana, 44 ((4)): (317-323). [PMID:23314973]
61. Faisal A Khasawneh,Adeline J Jou-Tindo. (2013-05-08) A 30-year-old woman with recurrent lower respiratory tract infections.. Chest, 143 ((5)): (1500-1503). [PMID:23648915]
62. Chee Wee Gan,Wai Hon Chooi,Herr Cheun Anthony Ng,Yee Shan Wong,Subbu S Venkatraman,Lynne Hsueh Yee Lim. (2013-05-15) Development of a novel biodegradable drug-eluting ventilation tube for chronic otitis media with effusion.. The Laryngoscope, 123 ((7)): (1770-1777). [PMID:23666715]
63. Kwok-Chiu Chang,Keertan Dheda. (2013-07-03) Rationalizing use of fluoroquinolones and pyrazinamide in the battle against multidrug-resistant tuberculosis.. American journal of respiratory and critical care medicine, 188 ((1)): (10-11). [PMID:23815718]
64. Jeong-Ah Kim,Jung Hwa Ko,Ah Young Ko,Hyun Ju Lee,Mee Kum Kim,Won Ryang Wee,Ryang Hwa Lee,Samuel F Fulcher,Joo Youn Oh. (2014-07-19) TSG-6 protects corneal endothelium from transcorneal cryoinjury in rabbits.. Investigative ophthalmology & visual science, 55 ((8)): (4905-4912). [PMID:25034606]
65. Ana P Tedim,Patricia Ruiz-Garbajosa,Jukka Corander,Concepción M Rodríguez,Rafael Cantón,Rob J Willems,Fernando Baquero,Teresa M Coque. (2014-12-31) Population biology of intestinal enterococcus isolates from hospitalized and nonhospitalized individuals in different age groups.. Applied and environmental microbiology, 81 ((5)): (1820-1831). [PMID:25548052]
66. Tzu-Yun Tsai,Ta-Ching Chen,I-Jong Wang,Chao-Yuan Yeh,Ming-Jai Su,Ruey-Hua Chen,Tzu-Hsun Tsai,Fung-Rong Hu. (2015-02-12) The effect of resveratrol on protecting corneal epithelial cells from cytotoxicity caused by moxifloxacin and benzalkonium chloride.. Investigative ophthalmology & visual science, 56 ((3)): (1575-1584). [PMID:25670486]
67. Manli Liu,Yuan Sun,Danyang Wang,Ting Zhang,Yugui Zhou,Hua Zheng,Quan Liu. (2015-03-06) Decentration of optical zone center and its impact on visual outcomes following SMILE.. Cornea, 34 ((4)): (392-397). [PMID:25742387]
68. Ming-Ming Zhai,Hai-Tao Niu,Jie Li,Hui Xiao,Yan-Ping Shi,Duo-Long Di,Phillip Crews,Quan-Xiang Wu. (2015-10-16) Talaromycolides A-C, Novel Phenyl-Substituted Phthalides Isolated from the Green Chinese Onion-Derived Fungus Talaromyces pinophilus AF-02.. Journal of agricultural and food chemistry, 63 ((43)): (9558-9564). [PMID:26466717]

Solution Calculators

Molarity Calculator

Determine the necessary mass, volume, or concentration for preparing a solution.

Dilution Calculator

Determine the dilution needed to prepare a stock solution.